Bøger af Sarfaraz K. Niazi
-
- Bog
- 525,95 kr.
-
525,95 kr. In recent years, there have been significant changes to the statistical models for evaluating bioequivalence. In addition, advances in the analytical technology used to detect drug and metabolite levels have made bioequivalence testing more complex. The second edition of this book has been completely updated to include the most current informati
- Bog
- 525,95 kr.
-
525,95 kr. The focus of this book is on how the US FDA will approve biosimilar drugs. The European scene is well developed with specific guidelines that are already in place. However, these guidelines do not apply to the thinking of the FDA in approving these products.
- Bog
- 525,95 kr.
-
525,95 - 1.184,95 kr. - Bog
- 525,95 kr.
-
- Bog
- 525,95 kr.
-
- Bog
- 2.278,95 kr.
-
- Regulatory, Manufacturing, Testing, and Patent Issues
793,95 kr. Handbook of Biogeneric Therapeutic Proteins is the first book to offer extensive coverage of all aspects of generic and biosimilar biological products, from the scientific basis through the marketing issues. This practical book includes comprehensive information on establishing a manufacturing system and securing regulatory approval for biogeneric
- Bog
- 793,95 kr.
-
525,95 - 5.978,95 kr. - Bog
- 525,95 kr.
-
525,95 - 2.473,95 kr. - Bog
- 525,95 kr.
-
- A Professional Guide
1.271,95 kr. Describes various steps in filing and prosecuting an online patent. This book teaches the methods of research, planning, and the art of writing winning claims that will result in commercially valuable patents.
- Bog
- 1.271,95 kr.
-
- Bog
- 2.388,95 kr.
-
- The FDA Perspective
2.258,95 kr. The focus of this book is on how the US FDA will approve biosimilar drugs. The European scene is well developed with specific guidelines that are already in place. However, these guidelines do not apply to the thinking of the FDA in approving these products.
- Bog
- 2.258,95 kr.
-
2.388,95 kr. - Bog
- 2.388,95 kr.
-
2.513,95 kr. - Bog
- 2.513,95 kr.